Nasus Pharma Ltd.

Drug Manufacturers - General • Healthcare • Tel Aviv-Yafo, Israel • NSRX (ASE)

Nasus Pharma Ltd. operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.

972 3 573 6632 Yigal Alon 65, Israel

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Nasus Pharma highlights transformational 2025 as NS002 intranasal epinephrine program advances and IPO completes - MSN

MSN • Dec 23

Nasus Pharma Highlights Transformational 2025 as NS002 Intranasal Epinephrine Program Advances and IPO Completes - TipRanks

TipRanks • Dec 22

Citizens initiates Nasus Pharma stock with Market Outperform rating By Investing.com - Investing.com Nigeria

Investing.com Nigeria • Dec 18

Nasus Pharma Announces Pricing of $10 Million Initial Public Offering - Yahoo Finance

Yahoo Finance • Aug 13

Nasus Pharma prices $10 million IPO - The Pharma Letter

The Pharma Letter • Aug 14

Other Drug Manufacturers - General Companies

Frequently Asked Questions

Has Nasus Pharma Ltd had layoffs?

No layoff events have been recorded for Nasus Pharma Ltd in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Nasus Pharma Ltd have?

Nasus Pharma Ltd has approximately 1 employees.

What industry is Nasus Pharma Ltd in?

Nasus Pharma Ltd operates in the Drug Manufacturers - General industry, within the Healthcare sector.

Is Nasus Pharma Ltd a publicly traded company?

Yes, Nasus Pharma Ltd is publicly traded under the ticker symbol NSRX on the ASE. The company has a market capitalization of approximately $0.07 billion.

Where is Nasus Pharma Ltd headquartered?

Nasus Pharma Ltd is headquartered in Tel Aviv-Yafo, Israel at Yigal Alon 65, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.